DiscGenics Raises $14 Million for Injectable Cell Therapy
DiscGenics closed a US $14MM Series B financing. Funds will support regulatory approvals and manufacturing ramp-up for Phase III clinical...
DiscGenics closed a US $14MM Series B financing. Funds will support regulatory approvals and manufacturing ramp-up for Phase III clinical...
Paragon 28 launched posterior plates for its Gorilla® Ankle Fracture system....
Viseon Spine closed a US $5.0MM Series A financing. The company is developing single-use, disposable visualization and illumination technologies for minimally invasive...
New product launches from Flower Orthopedics include updated instruments in the Flower E-Kit™ system; FlowerGraft™, a foot reconstruction platform with pre-shaped allografts packaged...
LifeLink Tissue Bank will provide allografts to treat sports, orthopaedic and spine injuries to HCT Regenerative, for distribution in Taiwan. ...
Amedica announced preliminary 1Q17 revenue of US $2.6MM, -37.7% vs. 1Q16, and 2Q17 revenue of $3.2MM, -20.0% vs. 2Q16, totaling preliminary...
Integra LifeSciences implanted the first Cadence® Total Ankle as part of a non-randomized, prospective, multi-center postmarket study....
Bone Therapeutics signed an exclusive license agreement with Asahi Kasei to develop and commercialize PREOB® autologous bone cell therapy....
The majority of the spine market-just about 80%-is controlled by companies with annual spine revenue above $100 million. See a...
SpinalCyte was issued Australian Patent No. 2015202319, “Methods and Compositions for Repair of Cartilage Using an In Vivo Bioreactor.”...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.